ICCC Key Stats
|Revenue (Quarterly YoY Growth)||14.67%|
|EPS Diluted (TTM)||0.0844|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||0.2512M|
|Gross Profit Margin (Quarterly)||49.87%|
|Profit Margin (Quarterly)||4.64%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
- IMMUCELL CORP /DE/ Financials Nov 21
- IMMUCELL CORP /DE/ Files SEC form 10-Q, Quarterly Report Nov 13
- Immucell Corp (ICCC) Reports Q3 EPS of $0.02 Street Insider Nov 12
- IMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition Nov 12
- ImmuCell Announces Increased Product Sales and Continued Profitability Marketwired Nov 12
- IMMUCELL CORP /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Sep 23
- RAIT Financial Trust Part Owner Buys 170K Shares and 4 Insider Buys to Note Aug 19
- IMMUCELL CORP /DE/ Files SEC form 10-Q, Quarterly Report Aug 13
- IMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition Aug 12
- ImmuCell Announces Increase in Product Sales and Continued Profitability Marketwired Aug 12
ICCC Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ImmuCell is up 1.86% over the last year vs S&P 500 Total Return up 28.99%, Agilent Technologies up 43.71%, and Abaxis down 4.94%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for ICCC
Pro Strategies Featuring ICCC
Did ImmuCell make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
ImmuCell Corporation is engaged in the development, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries.